Literature DB >> 16594978

Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.

S Middei1, S Daniele, A Caprioli, O Ghirardi, M Ammassari-Teule.   

Abstract

The possibility of detecting progressive changes in cognitive function reflecting the spatio-temporal pattern of beta-amyloid peptide (Abeta) deposition was investigated in Tg2576 mice overexpressing the human mutant amyloid precursor protein (hAPP). Here, we show that at 7 months of age, Tg2576 mice exhibited a selective deficit in hippocampus-based operations including a defective habituation of object exploration, a lack of reactivity to spatial novelty and a disruption of allothetic orientation in a cross-shaped maze. At 14 months of age, Tg2576 mice displayed a more extended pattern of behavioral abnormalities, because they failed to react to object novelty and exclusively relied on motor-based orientation in the cross-shaped maze. However, an impaired reactivity to spatial and object novelty possibly reflecting age-related attention deficits also emerged in aged wild-type mice. These findings further underline that early cognitive markers of AD can be detected in Tg2576 mice before Abeta deposition occurs and suggest that as in humans, cognitive deterioration progressively evolves from an initial hippocampal syndrome to global dementia because of the combined effect of the neuropathology and aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16594978     DOI: 10.1111/j.1601-183X.2005.00160.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  7 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment.

Authors:  Alice L Blackshear; Wenjin Xu; Maria Anderson; Feng Xu; Mary Lou Previti; William E Van Nostrand; John K Robinson
Journal:  Neurobiol Learn Mem       Date:  2011-07-08       Impact factor: 2.877

3.  VPS35 haploinsufficiency increases Alzheimer's disease neuropathology.

Authors:  Lei Wen; Fu-Lei Tang; Yan Hong; Shi-Wen Luo; Chun-Lei Wang; Wanxia He; Chengyong Shen; Ji-Ung Jung; Fei Xiong; Dae-hoon Lee; Quan-Guang Zhang; Darrell Brann; Tae-Wan Kim; Riqiang Yan; Lin Mei; Wen-Cheng Xiong
Journal:  J Cell Biol       Date:  2011-11-21       Impact factor: 10.539

4.  Modeling of age-dependent amyloid accumulation and γ-secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition.

Authors:  Joanna Parkinson; Bart Ploeger; Paulina Appelkvist; Anna Bogstedt; Karin Dillner Bergstedt; Susanna Eketjäll; Sandra A G Visser
Journal:  Pharmacol Res Perspect       Date:  2013-12-05

5.  Place vs. Response Learning: History, Controversy, and Neurobiology.

Authors:  Jarid Goodman
Journal:  Front Behav Neurosci       Date:  2021-02-11       Impact factor: 3.558

Review 6.  Cholinergic regulation of object recognition memory.

Authors:  Kana Okada; Kouichi Hashimoto; Kazuto Kobayashi
Journal:  Front Behav Neurosci       Date:  2022-09-29       Impact factor: 3.617

7.  Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels.

Authors:  Patricia A Lawlor; Ross J Bland; Pritam Das; Robert W Price; Vallie Holloway; Lisa Smithson; Bridget L Dicker; Matthew J During; Deborah Young; Todd E Golde
Journal:  Mol Neurodegener       Date:  2007-06-09       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.